Whole genome-based characterization of extended-spectrum -lactamase-producing from orthopedic patients and environment of a tertiary referral hospital in Tanzania.

OBJECTIVES

We investigated the genomic epidemiology of extended-spectrum -lactamase-producing (ESBL-Ec) isolates from patients and hospital environment to better understand their distribution to help devising effective strategies for infection prevention and control.

METHODS

We screened ESBL-Ec at Bugando Medical Center (BMC) in Mwanza, Tanzania. Rectal swabs from orthopedic patients on admission and swabs from the neighboring inanimate environment were collected. Following microbial culture, DNA was extracted from pure ESBL-Ec, and whole-genome sequencing was done. Sequence typing (ST), plasmid replicons, drug resistance, and virulence genes were deciphered using the Rapid Microbial Analysis Pipeline (rMAP).

RESULTS

We obtained 209 ESBL isolates, of which 15 (7.2 %) were ESBL-Ec [8 (53.3 %) from patients and 7 (46.7 %) from the environment]. Seven isolates were novel and eight were diverse, each with a unique ST. All isolates harbored two to five -lactamase genes, with the predominance of (15/15 (14/15) (14/15) and (12/15). The most common non β-lactam drug resistance genes were (14/15 (14/15) (14/15 and (12/15 (10/15) and (10/15) Eleven different types of plasmid replicons were identified in 14/15 of the isolates, harboring one to five plasmids, with the most common plasmids being (11/15) and (10/15). All isolates harbored the outer membrane protein (A), and curli protein ) was in 14/15 isolates.

CONCLUSION

Admitted orthopedic patients and the hospital environment act as a reservoir of ESBL-Ec with diverse STs and endowed with drug resistance and arsenals of virulence genes, calling for their routine screening on admission for mitigation of potential subsequent infections.